Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9

British Journal of Dermatology

Volumn 137, Issue 4, 1997, Pages 506-516

  Tarlton, J F ^a   Vickery, C J ^b   Leaper, D J ^c   Bailey, A J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HUMAN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INCISION; WOUND HEALING;

BIOLOGICAL MARKERS; CHRONIC DISEASE; COLECTOMY; COLLAGENASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXUDATES AND TRANSUDATES; FEMALE; GELATINASES; HUMANS; LEG ULCER; MASTECTOMY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; POSTOPERATIVE PERIOD; WOUND HEALING;

EID: 0030775242     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03779.x     Document Type: Article

References (45)

1. Nagase H. Matrix metalloproteinases - a mini-review. In: Extracellular Matrix in the Kidney (Koide H, Hayashi T, eds). Contributions to Nephrology, Vol. 107. Basel: Karger, 1994; 85-93.
2. Murphy G. Matrix metalloproteinases and their inhibitors (review). Acta Orthop Stand Suppl 1995; 266: 55-60.
3. Matrisian LM. The matrix-degrading metalloproteinases (review). Bioessays 1992; 14: 455-63.
4. Zhou H, Bernhard EJ, Fox FE, Billings PC. Induction of metalloproteinase activity in human T-lymphocytes. Biochim Biophys Acta 1993; 1177: 174-8.
5. Madri JA, Pratt BM. Angiogenesis. In: The Molecular and Cellular Biology of Wound Repair (Clark RAF, Henson PM, eds). New York: Plenum Press, 1988; 337-58.
6. Mauviel A. Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 1993; 53: 288-95.
7. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 1995; 376: 345-55.
8. Delclaux C, Delacourt C, D'Ortho MP, et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996; 14: 288-95.
9. Schnaper HW, Grant DS, Stetler-Stevenson WG, et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 1993; 156: 235-46.
10. Sato H, Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993; 8: 395-405.
11. Trancart MM, Chalmeigne N, Girardot C, et al. Gelatinase is the main matrix metalloproteinase involved in granuloma-induced cartilage degradation. Int J Tissue React 1992; 14: 287-94.
12. Murphy G. The biochemical and cellular functions of the matrix metalloproteinases. In: Proteolysis in Wound Repair (Abatangelo G, Donati L, Vanscheidt W, eds). Berlin: Springer-Verlag, 1996; 13-19.
13. Gailit J, Clark RA. Wound repair in the context of extracellular matrix. Curr Opin Cell Biol 1994; 6: 717-25.
14. Basbaum CB, Werb Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol 1996; 8: 731-8.
15. Salo T, Makela M, Kylmaniemi M, et al. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 1994; 70: 176-82.
16. Oikarinen A, Kylmaniemi M, Autio-Harmainen H, et al. Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J Invest Dermatol 1993; 101: 205-10.
17. Murphy G, Docherty AJP. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992; 7: 120-5.
18. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1995; 101: 64-8.
19. Meikle MC, Bord S, Hembry RM, Reynolds JJ. The synthesis of collagenase, gelatinase-A (72kDa) and -B (95kDa), and TIMP-1 and -2 by human osteoblasts from normal and arthritic bone. Bone 1995; 17: 255-60.
20. Stetler-Stevenson WG, Liotta LA, Kleiner DJ. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993; 7: 1454-41.
21. Agren MS, Mertz PM. Collagenase during burn wound healing: influence of a hydrogel dressing and pulsed electrical stimulation. Plast Reconstr Surg 1994; 94: 518-24.
22. Agren MS, Mertz, PM. Are excessive granulation tissue formation and retarded wound contraction due to decreased collagenase activity in wounds in tight-skin mice? Br J Dermatol 1994; 131: 557-40.
23. Girard MT, Matsubara M, Kublin C, et al. Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remodeling. J Cell Sci 1995; 104: 1001-11.
24. Young PK, Grinnell F. Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment. J Invest Dermatol 1994; 103: 660-4.
25. Bullen EC, Longaker MT, Updike DL, et al. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 1995; 104: 236-40.
26. Brown D, Chwa MM, Opbroek A, Kenney MC. Keratoconus corneas: increased gelatinolytic activity appears alter modification of inhibitors. Current Eye Res 1995; 12: 571-81.
27. Matsubara M, Girard MT, Kublin CL, et al. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev Biol 1991; 147: 425-39.
28. Mignatti P, Welgus HG, Rifkin DB. Role of degradative enzymes in wound healing. In: The Molecular and Cellular Biology of Wound Repair (Clark RAF, Henson PM, eds). New York: Plenum Press, 1988; 497-523.
29. Roberts RM, Mathialagan N, Duffy JY, Smith GW. Regulation and regulatory role of proteinase-inhibitors. Crit Rev Eukaryotic Gene Expression 1995; 5: 385-436.
30. de Clerck YA, Alvarez O, Shimada H, et al. Tissue inhibitors of metalloproteinases: role in tumor progression. In: Extracellular Matrix in the Kidney (Koide H, Hayashi T, eds). Contributions to Nephrology, Vol. 107. Basel: Karger, 1994; 108-15.
31. Paul RG, Tarlton JF, Purslow PP, et al. Biomechanical and biochemical study of a standardised wound healing model. Int J Biochem Cell Biol 1947; 29: 211-20.
32. Mansell JP, Tarlton JF, Bailey AJ. Biochemical evidence for altered subchondral hone collagen metabolism in osteoarthritis of the hip. Br J Rheumatol 1997; 36: 16-19.
33. Tarlton JF, Knight PJ. Comparison of rellectance and transmission densitometry, using document and laser scanners, for quantitation of stained Western blots. Anal Biochem 1996; 237: 123-8.
34. Bannister DW, Burns AB. Adaptation of the Bergman and Loxley technique for hydroxyproline determination to the autoanalyzer and its use in determining plasma hydroxyproline in the domestic fowl. Analyst 1970; 95: 596-600.
35. Coldberg CI, Strongin A, Collier IE, et al. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992; 267: 4583-91.
36. Ogata Y, Itoh Y, Nagase H. Steps involved in activation of the promatrix metalloproteinase 9 (progelatinase B) -tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J Biol Chem 1995; 270: 18506-11.
37. 2+ in activation and catalysis. J Biol Chem 1995; 270: 18563-9.
38. Borregaard N, Lollike K, Kjeldsen L, et al. Human neutrophil granules and secretory vesicles. Eur J Haematol 1993; 51: 187-98.
39. Kjeklsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-assonated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 1994; 83: 799-807.
40. Murphy G, Crabbe T, Gelatinases A and B. In: Proteolytic Enzymes: Aspartic and Metallo Peptidases (Barrett AJ, ed.). Methods in Enzymology, Vol. 248. San Diego, CA: Academic Press, 1995; 470-84.
41. Mignatti P, Tsuboi R, Robbins E, Rifkin DB. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol 1989; 108: 671-82.
42. Maragoudakis ME, Peristeris P, Missirlis E, et al. Inhibition of angiogenesis by anthracyclines and titanocene dichloride. Ann NY Acad Sci 1994; 732: 280-93.
43. Weckroth M, Vaheri A, Lauharanta J, et al. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 1996; 106: 1119-24.
44. Skalli O, Gabbiani G. The biology of the myofibroblast relationship to wound contraction and fibrocontractive diseases. In: The Molecular and Cellular Biology of Wound Repair (Clark RAF, Henson PM, eds). New York: Plenum Press, 1988; 373-402.
45. Prajapati R, Eastwood M, Brown R. Induction of proteases by mechanically loaded fibroblasts during contraction. Int J Exp Pathol 1996; 77: A1-25.